Immunophenotyping and oncogene amplifications in tumors of the papilla of Vater

Carcinomas of the ampulla of Vater are rare and assumed to generally arise from preexisting adenomas (adenoma–carcinoma sequence). Histologically, distinct subtypes can be distinguished that were shown to differ significantly in terms of clinical outcome. Since pathologists usually receive bioptic t...

Full description

Saved in:
Bibliographic Details
Published inVirchows Archiv : an international journal of pathology Vol. 453; no. 6; pp. 579 - 588
Main Authors Baumhoer, Daniel, Zlobec, Inti, Tornillo, Luigi, Dietmaier, Wolfgang, Wuensch, Peter H., Hartmann, Arndt, Sessa, Fausto, Ruemmele, Petra, Terracciano, Luigi M.
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer-Verlag 01.12.2008
Springer
Springer Nature B.V
Subjects
TMA
Online AccessGet full text

Cover

Loading…
More Information
Summary:Carcinomas of the ampulla of Vater are rare and assumed to generally arise from preexisting adenomas (adenoma–carcinoma sequence). Histologically, distinct subtypes can be distinguished that were shown to differ significantly in terms of clinical outcome. Since pathologists usually receive bioptic tissue samples of ampullary tumors obtained during endoscopy, accurate classification of carcinoma subtypes can sometimes be difficult on morphological criteria alone. We therefore performed immunohistochemistry using a panel of established marker proteins (CK7, CK20, p21, p27, ESA, bax, and ephrin-B2) on 175 carcinoma, 111 adenoma, and 152 normal mucosa specimens of the ampulla of Vater and identified distinct immunoprofiles for every carcinoma subtype. Fluorescence in situ hybridization analyses of therapeutic target genes (c-myc, EGFR1, CCND1, HER2) found CCND1 to represent the most frequently amplified gene in our series (7.5%).
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0945-6317
1432-2307
DOI:10.1007/s00428-008-0669-7